knowledge -WSS

knowledge

author：comprehensive 2025-10-02 23:47:10 - browse：2

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： The tragedy of Johnson & Johnson’s Covid vaccine

WSS

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Greece's new parliament sworn in following conservative party's election victory

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

3 killed, 8 injured in late

EU climate chief is concerned over the expansion of the coal industry in China

focus

knowledge

leisure time

How one medical school became remarkably diverse

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

ChatGPT in medicine: STAT answers readers' burning questions

Russians and Belarusians back at Wimbledon as war in Ukraine continues

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Virginia high school admissions case could be legal follow

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Elizabeth Holmes banned from government health programs

explore

3 killed, 8 injured in late

Why doctors need education on FDA device approval process

EU climate chief is concerned over the expansion of the coal industry in China

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

FDA clears AI tool for detecting skin cancer

Elon Musk announces 'temporary limits' for reading Twitter posts

hotspot

entertainment

hotspot

Wikipedia